2024-05-20 16:31:03 ET
Inovio Pharmaceuticals, Inc. (INO)
H.C. Wainwright 2nd Annual BioConnect Investor Conference Call
May 20, 2024, 12:30 PM ET
Company Participants
Jacqueline Shea - President & Chief Executive Officer
Michael Sumner - Chief Medical Officer
Presentation
Unidentified Analyst
Welcome to the H.C. Wainwright 2nd Annual BioConnect Investor Conference at Nasdaq.
For this session, we are glad to have Ms. Jacqueline Shea, President and CEO of Inovio, and Mr. Michael Sumner, Chief Medical Officer of Inovio [indiscernible]. Welcome....
Read the full article on Seeking Alpha
For further details see:
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)